期刊文献+

ASPP2以p53非依赖形式促进自噬引起Hep3B细胞凋亡 被引量:4

ASPP2 Promotes p53-independent Autophagy-induced Apoptosis in Hep3B Cells
下载PDF
导出
摘要 p53凋亡刺激蛋白2(apoptosis stimulating protein 2 of p53,ASPP2)能特异性地与p53蛋白结合并增强其促凋亡的功能,进而发挥抗肿瘤作用.本室前期研究发现,ASPP2可以通过p53-DRAM-自噬途径诱导细胞凋亡.在本研究中,利用ASPP2腺病毒感染Hep3B细胞(p53缺陷型肝癌细胞系)并用甲基磺酸(MMS)处理后;Calcein AM/PI和M30染色检测细胞凋亡;GFP-LC3质粒转染细胞后检测自噬;荧光定量PCR和免疫印迹检测自噬基因表达.结果表明,ASPP2在p53缺陷的Hep3B细胞内可诱导发生凋亡;在MMS存在和缺失条件下,Adr-ASPP2均引起自噬体水平升高及自噬基因的表达增加,且MMS协同Adr-ASPP2能使自噬水平增加;进一步用VPS34 siRNA和DRAM siRNA抑制自噬发现,细胞凋亡水平下降,说明由Adr-ASPP2诱发经损伤相关自噬调节蛋白(DRAM)介导的自噬参与了肝癌细胞系凋亡的发生.综上结果表明,ASPP2可以通过非p53依赖的DRAM介导自噬,并促进肝癌细胞凋亡.该研究可为肝癌的基因治疗提供新的思路. ASPP2 (apoptosis stimulating protein 2 of p53) binds to p53 specifically and enhance the pro-apoptotic function of p53, which plays a role in inhibiting tumor development. Adr-ASPP2 induces apoptosis through activating p53-DRAM-autophagy pathway. In this study, methyl methanesulfonate (MMS) was emplyed to stimulate Hep3B cells for 24 hours, then four different methods were used to detect autophage. Results: Adr-ASPP2 treatment induced autophagosome formation and expression of autophagy genes with and without MMS treatment. Moreover, ASPP2 combined with MMS induced higher autophagy level and higher level of gene expression. Both VPS34 and DRAM (damage-regulatedautophagy modulator) siRNAs inhibited autophagy and blocked more ASPP2-or ASSP2 combined with MMS-induced apoptosis, indicating that ASPP2 induced DRAM-mediated autophagy involves in apoptotic death in Hep3B cells. The results showed that ASPP2 induces p53-independent DRAM expression- mediated autophagy, which promotes hepatocarcinoma death via apoptosis. Our results supply new idea in the field of gene therapy for liver cancer.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2013年第7期636-642,共7页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金(No.81071843 30870853 30770742和30910103915) 北京市自然科学基金(No.7092045和7101005) 首都医科大学基础-临床合作研究基金(No.12JL-L05) 北京市肝病研究所基金(No.BJIH-01201)~~
关键词 p53凋亡刺激蛋白2(ASPP2) 损伤相关自噬调节蛋白(DRAM) 自噬 凋亡 ASPP2 ( apoptosis stimulating protein 2 of p53) DRAM ( damage-regulated autophagymodulator) autophagy apoptosis
  • 相关文献

参考文献20

  • 1Chen D, Padiernos E, Ding F, et al. Apoptosis-stimulatiing protein of p53-2 (ASPP2/53BP2L) is an E2F1 target gene [ J ]. Cell Death Differ, 2005, 12(4) :358-368.
  • 2Murray-Zmijewski F, Slee E A, Lu X. A complex barcode underlies the heterogeneous response of p53 to stress [ J]. Nat Rev Mol Cell Biol, 2008, 9(9) :702-712.
  • 3Kampa K M, Acoba J D, Chen D, et al. Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage response thresholds [ J]. Proc Natl Acad Sci USA, 2009, 106( 11 ) :4390-4395.
  • 4Notari M, Hu Y, Koch S, et al. Inhibitor of apoptosis- stimulating protein of p53 (iASPP) prevents senescence and is required for epithelial stratification [ J ]. Proc Natl Acad Sci USA, 2011, 108(40):16645-16650.
  • 5Wang Z, Liu Y, Takahashi M, et al. N terminus of ASPP2 binds to Ras and enhances Ras/ Raf/ MEK/ERK activation to promote oncogene-induced senescence [ J]. Proc Natl Acad Sci U S A, 2013, 110(1) :312-317.
  • 6Bergamaschi D, Samuels Y, Jin B, et al. ASPP1 and ASPP2: common activators of p53 family members [ J ]. Mol Cell Biol, 2004, 24(3) :1341-1350.
  • 7Rautou P E, Mansouri A, Lebrec D, et al. Autophagy in liver disease [J]. J Hepatol, 2010, 53(6) :1123-1134.
  • 8刘凯,徐树莹,徐斌,陈德喜,李宁.早期自噬在非酒精性脂肪肝中的保护作用[J].北京医学,2011,33(12):947-949. 被引量:14
  • 9刘凯,徐树莹,徐斌,陈德喜,李宁.晚期自噬在非酒精性脂肪肝中的促凋亡作用[J].北京医学,2011,33(12):950-952. 被引量:11
  • 10Crighton D, Wilkinson S, O' Prey J, et al. DRAM, a p53- induced modulator of autophagy, is critical for apoptosis [ J ]. Cell, 2006,126(1) : 121-134.

二级参考文献37

  • 1Singh R, Kanshik S, Wang Y, et al. Autophagy regulates lipid metabolism. Nature,2009,458:1131-1135.
  • 2Lure JJ, DeBerardinis RJ, Thompson CB. Autophagy in metazoans: cell survival in the land of plenty. Nat Rev Mol Cell Biol,2005,6: 439-448.
  • 3Czaja MJ. Autophagy in health and disease. Regulation of lipid metabolism and storage by autophagy: pathophysiological implications. Am J Physiol Cell Physiol,2010,298:C973-978.
  • 4Yang L, Li P, Fu S, et al. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab,2010, 11:467-478.
  • 5Liu HY, Hall J, Cao SY, et al. Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of Fox01-dependent expression of key autophagy genes by insulin. J Biol Chem,2009,284:31484-31492.
  • 6Codogno P, Meijer AJ. Autophagy: a potential link between obesity and insulin resistance. Cell Metab,2010,11:449-451.
  • 7Rautou PE, Mansouri A, Lebrec D, et al. Autophagy in liver diseases. J Hepatol,2010,53:1123-1134.
  • 8Chipuk JE, Kuwana T, Bouchier-Hayes L, et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science,2004,303:1010-1014.
  • 9Wang Y, Ausman LM, Russell RM, et al. Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax. J Nutr,2008,138:1866-1871.
  • 10Gao M, Yeh PY, Lu YS, et al. 0SU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma. Cancer Res,2008,68:9348-9357.

共引文献21

同被引文献76

  • 1孙倩,王进科.ASPP2基因启动子区DNA甲基化及转录因子DNA结合位点的干湿研究[J].生物医学工程研究,2010,29(4):254-258. 被引量:1
  • 2Hildesheim A,Wang CP.Genetic predisposition factors and nasopharyngeal carcinoma risk:A review of epidemiological association studies,2000-2011:Rosetta Stone for NPC:Genetics,viral infection,and other environmental factors[J].Semin Cancer Biol,2012,22(2):107-116.
  • 3Secondino S,Zecca M,Licitra L,et al.T-cell therapy for EBV-associated nasopharyngeal carcinoma:Preparative lymphodepleting chemotherapy does not improve clinical results[J].Ann Oncol,2012,23(2):435-441.
  • 4Kong L,Hu C,Niu X,et al.Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma:Interim results from 2 prospective phase 2 clinical trials[J].Cancer,2013,119(23):4111-4118.
  • 5Xue C,Huang Y,Huang PY,et al.Phase Ⅱ study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma[J].Ann Oncol,2013,24(4):1055-1061.
  • 6Gu MF,Liu LZ,He LJ,et al.Sequential chemoradiotherapy with gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma[J].Int J Cancer,2013,132(1):215-223.
  • 7Xu Y,Yu H,Qin H,et al.Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells[J].Cancer Lett,2012,314(2):232-243.
  • 8Rovetta F,Stacchiotti A,Consiglio A,et al.ER signaling regulation drives the switch between autophagy and apoptosis in NRK-52E cells exposed to cisplatin[J].Exp Cell Res,2012,318(3):238-250.
  • 9Stankov MV,El KM,Kumar TB,et al.Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy[J].Leukemia,2014,28(3):577-588.
  • 10Takahashi A,Kimura T,Takabatake Y,et al.Autophagy guards against cisplatin-induced acute kidney injury[J].Am J Pathol,2012,180(2):517-525.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部